Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Optima Pharma GmbH currently has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. This focused activity reflects a targeted investment in protecting medical and mechanical innovations. The 2 pending actions represent the company's current efforts to navigate the federal patent examination process.
The prosecution is handled by 2 distinct examiners across 2 distinct art units. This 1:1 ratio between actions and examiners indicates that each matter is being reviewed independently by a different person in a different administrative division. This structure ensures that the 2 pending matters are evaluated without the concentrated influence of a single examiner.
NIESZ, JASON KAROL is identified as the busiest examiner, currently managing 1 busiest examiner pending office action. Because this examiner is responsible for only 1 of the 2 total actions, the workload is perfectly balanced. Success in the Medical Devices & Mechanical Engineering sector for these filings will require meeting the distinct expectations of 2 different examiners in 2 separate art units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FERRERO, EDUARDO R | 1 | 61.7% | +43.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694602 | METHOD AND DEVICE FOR REMEDYING DISTURBANCES IN A FILLING AND/OR SEALING AND/OR POST-PROCESSING INSTALLATION | FERRERO, EDUARDO R | 12d |
| Art Unit | Apps |
|---|---|
| 3731 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694602 | METHOD AND DEVICE FOR REMEDYING DISTURBANCES IN A FILLING AND/OR SEALING AND/OR POST-PROCESSING INSTALLATION | FERRERO, EDUARDO R | 3731 | §112 | Final Rejection | 12d | Pending | Mar 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOptima Pharma GmbH has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Eduardo R Ferrero has the most, with 1 of Optima Pharma GmbH's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
